Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Modified-Release Drug Delivery Systems: Classification

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

Modified-Release Drug Delivery Systems: Rate-Programmed I

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reducing the Formation of Toxic Byproducts During the Photochemical Release of Epinephrine.

Journal of xenobiotics·2025

Same author

Prototype of Implant for Nitric Oxide Release Controlled by Infrared Radiation in Therapeutic Window.

Journal of biophotonics·2024

Same author

Adrenochrome formation during photochemical decomposition of "caged" epinephrine derivatives.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2024

Same author

Platelet activation near point-like source of agonist: Experimental insights and computational model.

PloS one·2024

Same author

Nitric Oxide Photorelease from Silicone Films Doped with N-Nitroso BODIPY.

Journal of functional biomaterials·2024

Same author

Wireless monitoring of cell cultures based on light scattering: A novel optical scheme and portable prototype.

Journal of biophotonics·2023

Search research articles

Related Experiment Video

Updated: May 25, 2026

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

Platelets as Programmable Drug Depots: Toward Predictive and Mechanistic Drug Loading.

Alexander E Moskalensky¹

¹Research Center for Translational Medicine, Sirius University of Science and Technology, Sirius 354340, Russia.

Molecular Pharmaceutics

|May 23, 2026

Summary

This summary is machine-generated.

Platelet granules can be engineered as programmable drug depots. Rational design strategies, using physicochemical principles and computational modeling, optimize drug loading and release for advanced drug delivery systems.

Keywords:

biomimetic carriers blood platelets drug delivery storage granules vesicular transporters

More Related Videos

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Related Experiment Videos

Last Updated: May 25, 2026

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Area of Science:

Biomedical Engineering
Pharmaceutical Science
Nanotechnology

Background:

Efficient drug delivery faces challenges with synthetic nanocarriers in biological systems.
Blood platelets offer potential as biomimetic carriers, but their drug storage capacity is underutilized.

Purpose of the Study:

To propose platelet granules as programmable drug depots.
To outline a framework for rational control of drug loading and release.
To enable model-guided engineering of platelet-based drug delivery platforms.

Main Methods:

Utilizing physicochemical principles for passive accumulation (ion trapping).
Leveraging endogenous transport mechanisms for active uptake.
Applying computational modeling, molecular descriptors, and machine learning for prediction and optimization.

Main Results:

Demonstrated a conceptual design loop linking prediction and molecular optimization.
Identified pathways for rational control over drug loading into platelet granules.
Showcased potential for predicting and enhancing drug compatibility and accumulation efficiency.

Conclusions:

Platelets can be engineered as programmable drug depots beyond simple biomimetic carriers.
Rational design strategies can optimize drug loading and release kinetics.
This approach bridges biological systems with engineering principles for advanced drug delivery.